Letter to the Editor
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 28, 2024; 30(44): 4738-4740
Published online Nov 28, 2024. doi: 10.3748/wjg.v30.i44.4738
Diagnostic delay in inflammatory bowel disease: Current situation and problems
Cong Dai, Yu-Hong Huang, Min Jiang
Cong Dai, Yu-Hong Huang, Min Jiang, Department of Gastroenterology, First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China
Author contributions: Jiang M generated the original idea, formulated the protocol, and analyzed data; Dai C and Jiang M organized opinions and wrote the paper; Dai C, Huang YH, and Jiang M reviewed and approved the final draft of the paper.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Min Jiang, PhD, Professor, Department of Gastroenterology, First Hospital of China Medical University, No. 92 Beier Road, Heping District, Shenyang 110001, Liaoning Province, China. congdai2006@126.com
Received: July 4, 2024
Revised: October 14, 2024
Accepted: October 24, 2024
Published online: November 28, 2024
Processing time: 130 Days and 19.8 Hours
Abstract

In this article, we comment on the article by Blüthner et al published recently. Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease, is a chronic relapsing and remitting condition primarily as a consequence of intestinal inflammation. It is important about adopting early and effective treatment to control clinical symptoms of IBD patients. Diagnostic delay can lead to adverse clinical outcomes and increase disease burden. Diagnostic delay is multifactorial. There are some factors related to diagnostic delay, such as patient factors and healthcare factors. We focus on the diagnostic tools for IBD, the outcomes and factors of diagnostic delay of IBD.

Keywords: Inflammatory bowel disease; Ulcerative colitis; Crohn’s disease; Diagnostic delay; Clinical outcome

Core Tip: Inflammatory bowel disease, including ulcerative colitis and Crohn’s disease, is a chronic relapsing and remitting condition primarily as a consequence of intestinal inflammation. It is important about adopting early and effective treatment to control clinical symptoms of inflammatory bowel disease patients. Diagnostic delay can lead to adverse clinical outcomes and increase disease burden. Diagnostic delay is multifactorial. There are some factors related to diagnostic delay, such as patient factors and healthcare factors.